1. Home
  2. ACLX vs BCC Comparison

ACLX vs BCC Comparison

Compare ACLX & BCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACLX
  • BCC
  • Stock Information
  • Founded
  • ACLX 2015
  • BCC 2004
  • Country
  • ACLX United States
  • BCC United States
  • Employees
  • ACLX N/A
  • BCC N/A
  • Industry
  • ACLX Biotechnology: Pharmaceutical Preparations
  • BCC RETAIL: Building Materials
  • Sector
  • ACLX Health Care
  • BCC Consumer Discretionary
  • Exchange
  • ACLX Nasdaq
  • BCC Nasdaq
  • Market Cap
  • ACLX 3.5B
  • BCC 3.2B
  • IPO Year
  • ACLX 2022
  • BCC 2013
  • Fundamental
  • Price
  • ACLX $69.02
  • BCC $91.16
  • Analyst Decision
  • ACLX Strong Buy
  • BCC Buy
  • Analyst Count
  • ACLX 14
  • BCC 7
  • Target Price
  • ACLX $111.42
  • BCC $120.17
  • AVG Volume (30 Days)
  • ACLX 533.5K
  • BCC 368.7K
  • Earning Date
  • ACLX 08-07-2025
  • BCC 08-04-2025
  • Dividend Yield
  • ACLX N/A
  • BCC 6.41%
  • EPS Growth
  • ACLX N/A
  • BCC N/A
  • EPS
  • ACLX N/A
  • BCC 8.04
  • Revenue
  • ACLX $76,809,000.00
  • BCC $6,615,368,000.00
  • Revenue This Year
  • ACLX N/A
  • BCC N/A
  • Revenue Next Year
  • ACLX $112.68
  • BCC $4.61
  • P/E Ratio
  • ACLX N/A
  • BCC $11.33
  • Revenue Growth
  • ACLX N/A
  • BCC N/A
  • 52 Week Low
  • ACLX $47.86
  • BCC $83.60
  • 52 Week High
  • ACLX $107.37
  • BCC $155.42
  • Technical
  • Relative Strength Index (RSI)
  • ACLX 62.53
  • BCC 53.32
  • Support Level
  • ACLX $67.46
  • BCC $89.34
  • Resistance Level
  • ACLX $69.63
  • BCC $95.00
  • Average True Range (ATR)
  • ACLX 2.10
  • BCC 2.77
  • MACD
  • ACLX 0.36
  • BCC 0.48
  • Stochastic Oscillator
  • ACLX 90.76
  • BCC 58.66

About ACLX Arcellx Inc.

Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.

About BCC Boise Cascade L.L.C.

Boise Cascade Co is a producer of engineered wood products (EWP) and plywood. The firm operates in two reportable segments, namely Wood Products and Building Materials Distribution. The Wood Products segment manufactures laminated veneer lumber (LVL), I-joists, and laminated beams. In addition, it manufactures structural, appearance, and industrial-grade plywood panels, and ponderosa pine lumber. The Building Materials Distribution segment is engaged in the distribution of various building materials, including oriented strand board (OSB), plywood, and lumber; general line items such as siding, composite decking, doors and millwork, metal products, roofing, and insulation; and EWP, among others. The company generates a majority of its revenue from the Building Material Distribution segment.

Share on Social Networks: